IXUP IP PTY LTD – Trademark Portfolio

Entity Type: 11

IXUP IP PTY LTD holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PLAYPAUSE and DATA REPUBLIC. The owner is based in NORTH SYDNEY.

SUITE 118-120 HIGH STREET

SUB BASE PLATYPUS

NORTH SYDNEY 2060 , AU

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

IXUP IP PTY LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (7 filings)

Scientific and technological services; industrial analysis and research services

35
Advertising & Business (6 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does IXUP IP PTY LTD have?

IXUP IP PTY LTD has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned.

What trademark classes does IXUP IP PTY LTD file in?

IXUP IP PTY LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.

What are IXUP IP PTY LTD's most well-known trademarks?

IXUP IP PTY LTD's registered trademark portfolio includes well-known marks such as PLAYPAUSE and DATA REPUBLIC. These are among 2 currently registered trademarks in the portfolio.

What is IXUP IP PTY LTD's trademark registration success rate?

IXUP IP PTY LTD has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.